Chinese COVID Vaccine BBIBP-CorV Shows Promise in Early Trial

FRIDAY, Oct. 16, 2020 — An experimental COVID-19 vaccine appeared to be safe and triggered an immune response in healthy people, according to preliminary results of a small, early-stage clinical trial.
The study of the vaccine based on inactivated…
Source: Topamax